https://doi.org/10.1038/s41588-023-01314-0
S
Sara Tomei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
2.2K
Citations
26
h-index
48
i10-index
Sara Tomei is an academic researcher from Qatar Airways (Qatar). The author has contributed to research in topics: Immunotherapy and Immune Responses & Melanoma and MAPK Pathways & Genetic Associations and Epidemiology. The author has an h-index of 26, co-authored 102 publications.
ORCID: 0000-0001-5334-9140Papers by this author
worksMulti-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
2023 · Nature Genetics · 173 citations
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
2013 · Journal of Translational Medicine · 104 citations
https://doi.org/10.1186/1479-5876-11-145
Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits
2021 · Nature Communications · 73 citations
https://doi.org/10.1038/s41467-021-21381-3
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
2013 · British Journal of Cancer · 61 citations
https://doi.org/10.1038/bjc.2013.335
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management
2015 · BMC Cancer · 52 citations
https://doi.org/10.1186/s12885-015-1917-2
A family harboring an MLKL loss of function variant implicates impaired necroptosis in diabetes
2021 · Cell Death and Disease · 32 citations
https://doi.org/10.1038/s41419-021-03636-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat